Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Voyager Therapeutics (NasdaqGS:VYGR) with a ...
Fintel reports that on January 10, 2025, Cantor Fitzgerald initiated coverage of Bright Minds Biosciences (NasdaqCM:DRUG) with a Overweight recommendation. Analyst Price Forecast Suggests 77.07% ...